相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis
Andrew Blauvelt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis
Holly Neale et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial
Hong-Xia Jia et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2020)
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators
Markus V. Heppt et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2020)
Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial
Kelly A. E. Sinx et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Interventions for basal, cell carcinoma of the skin
Jason Thomson et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Randomized Trial of Four Treatment Approaches for Actinic Keratosis
Maud H. E. Jansen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease
Gabriel E. Molina et al.
JAMA DERMATOLOGY (2019)
Targeting the Hedgehog Pathway in Cancer: Current Evidence and Future Perspectives
Daniel Girardi et al.
CELLS (2019)
Relative efficacy of 5-fluorouracil compared with other treatments among patients with actinic keratosis: A network meta-analysis
Yanhua Wu et al.
DERMATOLOGIC THERAPY (2019)
Guidelines of care for the management of primary cutaneous melanoma
Susan M. Swetter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention
Abby R. Rosenberg et al.
JCI INSIGHT (2019)
Conventional vs. daylight photodynamic therapy for patients with actinic keratosis on face and scalp: 12-month follow-up results of a randomized, intra-individual comparative analysis
E. Sotiriou et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Topical 5-fluorouracil in dermatologic disease
Garrett T. Prince et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results
Jacques Dantal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma
Maud H. E. Jansen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Guidelines of care for the management of basal cell carcinoma
Christopher Bichakjian et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Guidelines of care for the management of cutaneous squamous cell carcinoma
Murad Alam et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream A Randomized Clinical Trial
Martin A. Weinstock et al.
JAMA DERMATOLOGY (2018)
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy
Trevor J. Cunningham et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Effectiveness of photodynamic therapy in Bowen's disease: a retrospective observational study in 423 lesions
O. Zaar et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures
D. Tio et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
A phase I clinical trial demonstrates that nfP2X7-targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma
S. M. Gilbert et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
A systematic review of non-surgical treatments for lentigo maligna
T. Read et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial
Marieke H. Roozeboom et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
The effect of topical diclofenac 3% and calcitriol 3 mg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial
Tjinta Brinkhuizen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Photodynamic Therapy in Daylight for Actinic Keratoses
Hans Christian Wulf
JAMA DERMATOLOGY (2016)
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
Mina S. Ally et al.
JAMA DERMATOLOGY (2016)
Photodynamic Therapy for Non-Melanoma Skin Cancers
Diana K. Cohen et al.
CANCERS (2016)
Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75 % : a case report
Thomas Dirschka et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2016)
Twelve-week Treatment of Lentigo Maligna with Imiquimod Results in a High and Sustained Clearance Rate
Gudula Kirtschig et al.
ACTA DERMATO-VENEREOLOGICA (2015)
Usefulness of Photodynamic Therapy as a Possible Therapeutic Alternative in the Treatment of Basal Cell Carcinoma
Paola Savoia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance
Ariana N. Mora et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type
Susan M. Swetter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis A Randomized Clinical Trial
Hyemin Pomerantz et al.
JAMA DERMATOLOGY (2015)
European Dermatology Forum Guidelines on topical photodynamic therapy
Cohn Morton et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2015)
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial
D. M. Rubel et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma
Daniel J. Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study
S. R. Wiegell et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial
Fiona Bath-Hextall et al.
LANCET ONCOLOGY (2014)
Current evidence and applications of photodynamic therapy in dermatology
Marilyn T. Wan et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2014)
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review
A. K. Gupta et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial
Aimee H. M. M. Arits et al.
LANCET ONCOLOGY (2013)
Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies
Louise Lansbury et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Topical 5% Imiquimod in the Treatment of Lentigo Maligna
Jessica G. Wong et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2012)
Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group
A. Pflugfelder et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients
Danica Tiodorovic-Zivkovic et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2012)
Conservative Management of Extramammary Paget Disease With Imiquimod
Glauco Baiocchi et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2012)
Efficacy of Imiquimod Cream, 5%, for Lentigo Maligna After Complete Excision A Study of 43 Patients
Lena Ly et al.
ARCHIVES OF DERMATOLOGY (2011)
Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma
[Anonymous]
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
James Kim et al.
CANCER CELL (2010)
Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell Carcinoma
W. Elliot Love et al.
ARCHIVES OF DERMATOLOGY (2009)
Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up
A. M. Powell et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Imiquimod 5% Cream as Adjunctive Therapy For Primary, Solitary, Nodular Nasal Basal Cell Carcinomas Before Mohs Micrographic Surgery: A Randomized, Double Blind, Vehicle-Controlled Study
David F. Butler et al.
DERMATOLOGIC SURGERY (2009)
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma
Thomas K. Eigentler et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma
Lesley E. Rhodes et al.
ARCHIVES OF DERMATOLOGY (2007)
The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs)
L. F. Fecker et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
5% 5-fluorouracil cream for the treatment of small superficial basal cell carcinoma: Efficacy, tolerability, cosmetic outcome, and patient satisfaction
Kenneth Gross et al.
DERMATOLOGIC SURGERY (2007)
Treatment of Bowen's disease with topical 5% imiquimod cream: Retrospective study
Ted Rosen et al.
DERMATOLOGIC SURGERY (2007)
Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin
Cristina Zane et al.
LASERS IN SURGERY AND MEDICINE (2007)
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus
Lasse R. Braathen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Mining the Wnt pathway for cancer therapeutics
Nick Barker et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: A 3-year retrospective follow-up study
Y Vun et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2006)
Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomized, double-blind, placebo-controlled trial
GK Patel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ - Results of a multicenter randomized trial
C Morton et al.
ARCHIVES OF DERMATOLOGY (2006)
Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial
SR Wiegell et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Cyclooxygenase-2 overexpression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis
Jeng-Wei Tjiu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma:: results from a randomized vehicle-controlled phase III study in Europe
HJ Schulze et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis - Results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials
N Korman et al.
ARCHIVES OF DERMATOLOGY (2005)
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies
J Geisse et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Immunosuppressants and skin cancer in transplant patients: Focus on rapamycin
S Euvrard et al.
DERMATOLOGIC SURGERY (2004)
Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease
A Salim et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Topical treatment of Bowen's disease with 5-fluorouracil
H Bargman et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2003)
Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion
W Sterry et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma - Comparison of dosing regimens
S Shumack et al.
ARCHIVES OF DERMATOLOGY (2002)
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study
JK Geisse et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Topical treatment of actinic keratoses with 3.0% diclofcnac in 2.5% hyaluronan gel
JK Rivers et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses
JE Wolf et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2001)
Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum
B Hamouda et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Imiquimod 5% cream in the treatment of Bowen's disease
A Mackenzie-Wood et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
分享论文
